# A Single-Dose Study of an Investigational Capsule Formulation of 2 mg/0.5 mg Buprenorphine/Naloxone

> **NCT00880841** · — · COMPLETED · sponsor: **NanoSHIFT LLC** · enrollment: 6 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Buprenorphine / Naloxone

## Key facts

- **NCT ID:** NCT00880841
- **Lead sponsor:** NanoSHIFT LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2017-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00880841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00880841, "A Single-Dose Study of an Investigational Capsule Formulation of 2 mg/0.5 mg Buprenorphine/Naloxone". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00880841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*